Ignite Creation Date:
2025-12-24 @ 3:15 PM
Ignite Modification Date:
2025-12-24 @ 3:15 PM
Study NCT ID:
NCT04384692
Status:
RECRUITING
Last Update Posted:
2025-09-05
First Post:
2020-05-08
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-08
First Submit QC Date:
None
Study First Post Date:
2020-05-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-03
Last Update Post Date:
2025-09-05
Last Update Post Date Type:
ESTIMATED